• Mon, May 15, 2023
Graig Suvannavejh Maintained (AMLX) at Strong Buy with Decreased Target to $50 on, May 15th, 2023
Graig Suvannavejh of Mizuho, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Decreased Target from $52 to $50 on, May 15th, 2023.
Graig has made no other calls on AMLX in the last 4 months.
There are 3 other peers that have a rating on AMLX. Out of the 3 peers that are also analyzing AMLX, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $47 on, Tuesday, March 14th, 2023
These are the ratings of the 2 analyists that currently disagree with Graig
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Friday, May 12th, 2023
- Itay Michaeli of "Citigroup" Maintained at Strong Buy with Increased Target to $54 on, Tuesday, March 14th, 2023
Like: 👍
